Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Amyotrophic lateral sclerosis Stories

2013-10-29 08:34:18

Spasticity Ranked Among Top Three Post-Stroke Symptoms Impacting Patients IRVINE, Calif., Oct. 29, 2013 /PRNewswire/ -- Seventy percent of stroke survivors living with spasticity and their caregivers rank the debilitating condition as one of the top three symptoms impacting their life post-stroke, according to a recent survey conducted by Allergan, Inc. and National Stroke Association. Spasticity, which causes muscles to contract and spasm, causing stiffness and pain ranks second only to...

2013-10-29 08:33:35

TORONTO, Oct. 29, 2013 /PRNewswire/ -- An estimated 60,000 Americans will be diagnosed with Parkinson's disease this year, and nearly one million people in the U.S. are currently living with the chronic and progressive movement disorder. Understandably, a Parkinson's diagnosis causes many new patients to feel less optimistic about their future lives; according to the Parkinson's Disease Foundation, up to 60 percent of patients express depressive symptoms. There is a "chicken and...

2013-10-28 12:25:45

BROOMFIELD, Colo., Oct. 28, 2013 /PRNewswire/ -- Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications to address acute and chronic neurodegenerative diseases, announced today the publication of results in the peer-reviewed open access journal Neuropsychiatric Disease and Treatment. The study, titled "Retrospective Cohort Study of the Efficacy of Caprylic Triglyceride in Patients With...

2013-10-28 11:57:51

Mouse findings reverse prevailing theory; point to potential treatment options Researchers at the University of California, San Diego School of Medicine say that, while a prevailing theory suggests elevated cellular levels of glucose ultimately result in diabetic kidney disease, the truth may, in fact, be quite the opposite. The findings could fundamentally change understanding of how diabetes-related diseases develop – and how they might be better treated. Writing in the October 25...

2013-10-23 23:02:23

Seminar is open to the public on Saturday, Nov. 2 at Rapides Regional Medical Center in Alexandria, LA from 10 a.m. – 2 p.m. Shreveport, LA (PRWEB) October 23, 2013 The Muscular Dystrophy Association invites residents in the Ark-La-Tex area to fight back against muscle disease by participating in the "Living with a Muscle Disease" seminar on Saturday, Nov. 2 at Rapides Regional Medical Center in Alexandria, La. from 10 a.m. – 2 p.m. "Living with a Muscle Disease"...

2013-10-21 16:23:50

WASHINGTON, Oct. 21, 2013 /PRNewswire-USNewswire/ -- In work supported by The ALS Association, researchers have shown that critical aspects of the ALS disease process differ among different genetic forms of ALS. The study was published in the journal Experimental Neurology. ALS (amyotrophic lateral sclerosis), often referred to as Lou Gehrig's Disease, is a progressive neurodegenerative disease that affects neurons (nerve cells) in the brain and the spinal cord. Eventually, people...

2013-10-17 16:25:07

Announcement follows Congressman Fattah's meeting with NeuroVigil CEO, Dr. Philip Low WASHINGTON, Oct. 17, 2013 /PRNewswire-USNewswire/ -- A new technology that will enable patients suffering from ALS --commonly known as Lou Gehrig's Disease--to communicate via brain monitor, will hold its first clinical trials in Philadelphia. Congressman Chaka Fattah (PA-02) was on hand for the announcement, made Tuesday at the BrainTech Israel conference in Tel Aviv. The announcement came...

2013-10-17 08:28:56

-- PDE10 Target Engagement Continues to Increase with Well-Tolerated Doses - SEATTLE, Oct. 17, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced additional positive data from its Phase 1 program for OMS824, the lead compound in Omeros' phosphodiesterase 10 (PDE10) program. This latest clinical trial evaluated the extent to which OMS824, at a dose higher than previously reported, binds to PDE10, an enzyme expressed in the region of the brain that has been linked...

Researchers Discover And Treat Toxic Effects Of ALS Mutation Using Neurons Made From Patients' Skin Cells
2013-10-16 16:30:46

Cell Press Researchers have discovered how the most common genetic abnormality in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) kills neurons and have successfully developed a therapeutic strategy to block this neurodegeneration in neurons made from the skin cells of ALS patients. The findings, which are published online in the October 16th issue of the Cell Press journal Neuron, have important implications for treating patients with these debilitating, currently...

Proper And Timely Medical Help Often Lacking For Stroke Victims
2013-10-16 06:35:25

April Flowers for redOrbit.com - Your Universe Online Researchers in the UK have found that a majority of people diagnosed as having suffered a minor stroke or transient ischaemic attack (TIA) do not seek medical help in the timeframe recommended by the Royal College of Physicians. The study, published online in the journal Age and Ageing, found that of over 270 patients, only a small minority acted in a timely manner, despite a high profile FAST (Face or Arm weakness, Speech...